11 results match your criteria: "Tel-Aviv-Hebrew University[Affiliation]"
Int J Gynaecol Obstet
December 2023
Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat-Gan, Israel.
Objective: To evaluate the risk factors for a negative birth experience using the Birth Satisfaction Scale-Revised (BSS-R) questionnaire.
Methods: A cross-sectional study including women who gave birth at a single tertiary hospital between February 2021 and January 1, 2022. Birth satisfaction was measured using the BSS-R questionnaire.
Int J Gynaecol Obstet
March 2023
Faculty of Medicine, Tel-Aviv-Hebrew University, Tel-Aviv, Israel.
Objective: To study obstetric outcomes of a second pregnancy among women with a first ectopic pregnancy (EP) treated with methotrexate compared with laparoscopic salpingectomy.
Methods: A retrospective cohort study including all women with a first EP and a following pregnancy that concluded by delivery at ≥24 weeks of gestation between March 2011 and April 2021. Second pregnancy outcomes were compared between women treated with methotrexate and those treated with salpingectomy in their first pregnancy.
Int J Gynaecol Obstet
February 2023
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Objective: To study the association between the method of induction of labor (IOL) and perinatal outcomes, among women undergoing labor after cesarean (LAC) with no prior vaginal delivery.
Method: A retrospective study including all women with no prior vaginal delivery undergoing IOL for LAC between March 2011 and January 2021. Oxytocin administration following prelabor rupture of membranes (PROM), oxytocin administration only, extra-amniotic balloon, and amniotomy were compared.
Arch Gynecol Obstet
March 2023
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Hadassah-Hebrew University Medical Center, POB 12000, 91120, Ramat-GanJerusalem, Israel.
Key Message: Trial of labor among women who never delivered vaginally with hypertensive disorder is associated with nearly half the success rate of the general population.
Purpose: To study the trial of labor after cesarean (TOLAC) among women with hypertensive disorders and no prior vaginal delivery.
Methods: A retrospective cohort study was conducted including women with no prior vaginal delivery undergoing TOLAC during 2010-2020.
Int J Gynaecol Obstet
November 2022
The Department of Gynecologic Oncology, Hadassah Medical Center, Jerusalem, Israel.
Objective: To study induction of labor (IOL) at 39 weeks compared with expectant management among women undergoing labor after cesarean section (LAC) with no prior vaginal delivery.
Methods: A retrospective cohort study including all women undergoing LAC with no prior vaginal delivery, between March 2011 and January 2021. We allocated the study cohort into two groups: IOL at 39 to 39 and all LACs at ≥40 weeks of gestation.
Arch Gynecol Obstet
August 2022
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Purpose: To determine the factors associated with successful trial of labor after cesarean (TOLAC) among grand-multiparous (GMP) women.
Methods: A retrospective cohort study was conducted, including all GMP women (≥ 5 deliveries) undergoing TOLAC during 3/2011 and 6/2020, delivering a singleton cephalic newborn. Factors associated with successful vaginal delivery were examined by multivariable analysis.
Birth
June 2022
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Background: To study the factors associated with successful labor after cesarean (LAC) among women with no prior vaginal delivery, delivering a large for gestational age (LGA) baby.
Methods: A retrospective case-control study at two tertiary medical centers in Israel, including all women undergoing LAC with no prior vaginal delivery during 2010-2020, delivering a singleton LGA newborn. Factors associated with successful vaginal delivery were examined by a multivariable analysis.
Arch Gynecol Obstet
May 2022
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Purpose: We aimed to determine the factors associated with a successful trial of labor after cesarean (TOLAC) in the setting of preterm delivery of women with no prior vaginal delivery.
Methods: A retrospective cohort study conducted at two tertiary medical centers during 2010-2020, including all TOLACs with a single cesarean delivery and no prior vaginal delivery, delivering a singleton preterm newborn. Factors associated with successful vaginal delivery were examined by multivariable analysis.
Birth
March 2022
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Background: Data are scarce on predictors for success of labor after cesarean (LAC) among women delivering without epidural anesthesia (EA). We aimed to study the predictors for success of LAC among women with no prior vaginal delivery that did not use EA.
Methods: A retrospective study including all women undergoing LAC between 3/2011 and 1/2021 with no prior vaginal delivery that did not use EA.
Reprod Sci
February 2022
Department of Gynecologic Oncology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
To evaluate the characteristics and outcomes of women who had never delivered vaginally and underwent a trial of labor after cesarean (TOLAC) of small for gestational age (SGA) neonates, and to identify risk factors for unplanned repeat cesarean delivery. A retrospective cohort study from two tertiary medical centers. All women undergoing a TOLAC with no prior vaginal delivery, delivering a singleton SGA neonate at term between 2005 and 2020 were included.
View Article and Find Full Text PDFInt J Gynaecol Obstet
April 2022
Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Ramat-Gan, Israel.
Objective: To study the factors associated with successful trial of labor after cesarean (TOLAC) among women with diabetes and no prior vaginal delivery and compare with TOLAC in nondiabetic women.
Methods: A retrospective study including all women undergoing TOLAC who had no prior vaginal delivery between March 2011 and June 2020 at Sheba Medical Center. Women with diabetic disorders were compared with those without.